Abstract:Studies have demonstrated that the levels of phospholipids, including phosphatidylinositols (PIs), were decreased in Alzheimer's disease(AD) brain, presenting a potential biomarker for AD. The changes in plasma phospholipids were also discovered to predict phenoconversion of cognitively normal older adults. We used ion chromatography analysis to analyze PIs alterations in erythrocytes from a total of 86 subjects (24 normal controls (NC), 21 amnestic mild cognitive impairment (aMCI) patients and 41 AD patients). We found that PI36:2, PI40:4, PI3/5P, PI(3,4)P2 were significantly decreased in aMCI patients compared to normal control, and PI4P, PI(3,4)P2 and PI3/5P were significantly lower in AD patients compared to normal control. The changed expression profile of PIs could effectively discriminate AD or aMCI patients from normal controls. The changed expression profiles of PIs in AD or aMCI patients may present as a potential blood-based biomarker. This alteration of PIs probably reflected the impaired deformability and oxygen-carrying capacity of erythrocytes in AD and aMCI patients.

THE EXPRESSION PROFILE OF PHOSPHATIDYLINOSITOLS IN ERYTHROCYTES AS A POTENTIAL BIOMARKER FOR ALZHEIMER’S DISEASE AND AMNESTIC MILD COGNITIVE IMPAIRMENT